UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

Clinical cancer research, 2006-02, Vol.12 (4), p.1157-1167

2006

Volltextzugriff (PDF)

Abstract 5224: Next-generation sequencing of a panel of genes contributing to breast cancer risk

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.5224-5224

2016

Volltextzugriff (PDF)

Rad50 c.687delT Does Not Contribute Significantly to Familial Breast Cancer in a French Population

Cancer epidemiology, biomarkers & prevention, 2009-02, Vol.18 (2), p.684-685

2009

Volltextzugriff (PDF)

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome

JAMA : the journal of the American Medical Association, 2011-06, Vol.305 (22), p.2304

2011

Volltextzugriff (PDF)

Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population

International journal of medical sciences, 2013-01, Vol.10 (1), p.60-67

2013

Volltextzugriff (PDF)

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9742-9754

2010

Volltextzugriff (PDF)

Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer

Cancer, 2011-07, Vol.117 (14), p.3112-3117

2011

Volltextzugriff (PDF)

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

Nucleic acids research, 2012-01, Vol.40 (Database issue), p.D992

2012

Volltextzugriff (PDF)

Abstract 2602: CHEK2 contribution to hereditary breast cancer in non-BRCA famillies

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2602-2602

2012

Volltextzugriff (PDF)

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

PLoS biology, 2011-11, Vol.9 (11), p.e1001199

2011

Volltextzugriff (PDF)

Abstract 1842: Familial demonstration of the involvement of E-cadherine germ-line mutation in inherited invasive lobular breast carcinomas

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1842-1842

2010

Volltextzugriff (PDF)

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

Human molecular genetics, 2009-11, Vol.18 (22), p.4442-4456

2009

Volltextzugriff (PDF)

Molecular Analysis of the Breast Cancer Genes BRCA1 and BRCA2 Using Amplicon-Based Massive Parallel Pyrosequencing

The Journal of molecular diagnostics : JMD, 2012-11, Vol.14 (6), p.623-630

2012

Volltextzugriff (PDF)

BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases

International journal of medical sciences, 2008-07, Vol.5 (4), p.197-202

2008

Volltextzugriff (PDF)

Tu1908 HIF-1a Regulates CEACAM6 Expression in Response to Crohn's Disease-Associated E. coli Infection in a DNA Methylation Dependent Manner

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-875-S-875

2012

Volltextzugriff (PDF)

Abstract P1-03-06: BRCA1 and BRCA2 mutations in ethnic Lebanese Arab high risk women for hereditary breast cancer

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P1-P1-03-06

2015

Volltextzugriff (PDF)

Abstract 3988: Mutation screening of the BRCA genes using Roche-454 pyrosequencing: comparison with fluorescent dideoxy sequencing

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3988-3988

2010

Volltextzugriff (PDF)

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Human molecular genetics, 2010-07, Vol.19 (14), p.2886-2897

2010

Volltextzugriff (PDF)

Abstract 4669: Response to the anti-EGFR antibody panitumumab combined with standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC): the immune and IGFR pathways

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4669-4669

2013

Volltextzugriff (PDF)

Abstract 4854: Mutations activating proliferation pathways in ovarian cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4854-4854

2011

Volltextzugriff (PDF)

File n(o) 52: hTERT

Bulletin du cancer, 2004-05, Vol.91 (5), p.393

Uhrhammer, Nancy

2004

Volltextzugriff (PDF)

Chart #51: B-Raf (BRAF1, RAFB1, Rmil

Bulletin du cancer, 2004-02, Vol.91 (2), p.123

Uhrhammer, Nancy

2004

Volltextzugriff (PDF)

Cetuximab in combination with docetaxel (T) in patients with operable, triple-negative breast cancer (TNBC): Preliminary results of a multicentre neoadjuvant pilot phase II study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.1057-1057

2013

Volltextzugriff (PDF)

Response to the anti-EGFR antibody panitumumab combined with standard neoadjuvant chemotherapy in triple-negative breast cancer (TNBC): The immune and IGFR pathways

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.1058-1058

2013

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

KollektionPublisher website

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(36)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

Abstract 5224: Next-generation sequencing of a panel of genes contributing to breast cancer risk

Rad50 c.687delT Does Not Contribute Significantly to Familial Breast Cancer in a French Population

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome

Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

Common BRCA2 Variants and Modification of Breast and Ovarian Cancer Risk in BRCA1 Mutation Carriers

Abstract 2602: CHEK2 contribution to hereditary breast cancer in non-BRCA famillies

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

Abstract 1842: Familial demonstration of the involvement of E-cadherine germ-line mutation in inherited invasive lobular breast carcinomas

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

Molecular Analysis of the Breast Cancer Genes BRCA1 and BRCA2 Using Amplicon-Based Massive Parallel Pyrosequencing

BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases

Tu1908 HIF-1a Regulates CEACAM6 Expression in Response to Crohn's Disease-Associated E. coli Infection in a DNA Methylation Dependent Manner

Abstract P1-03-06: BRCA1 and BRCA2 mutations in ethnic Lebanese Arab high risk women for hereditary breast cancer

Abstract 3988: Mutation screening of the BRCA genes using Roche-454 pyrosequencing: comparison with fluorescent dideoxy sequencing

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Abstract 4669: Response to the anti-EGFR antibody panitumumab combined with standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC): the immune and IGFR pathways

Abstract 4854: Mutations activating proliferation pathways in ovarian cancer

File n(o) 52: hTERT

Chart #51: B-Raf (BRAF1, RAFB1, Rmil

Cetuximab in combination with docetaxel (T) in patients with operable, triple-negative breast cancer (TNBC): Preliminary results of a multicentre neoadjuvant pilot phase II study

Response to the anti-EGFR antibody panitumumab combined with standard neoadjuvant chemotherapy in triple-negative breast cancer (TNBC): The immune and IGFR pathways

Aktive Filter

Suchergebnisse filtern